#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Monogenic diabetes Pyruvate kinase deficiency anaemia Oesophageal adenocarcinoma stage II Mycobacterium abscessus infection Antiphospholipid syndrome PIK3CA-activated mutation C3 glomerulopathy Idiopathic intracranial hypertension Cholangitis sclerosing Vulval cancer recurrent Hyperoxaluria Dementia Systemic scleroderma Congenital aplastic anaemia More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Life with Disease Haemolytic uraemic syndrome – Basic Information Adrenocortical carcinoma – Diagnostics Rett syndrome – Life with Disease Synovial sarcoma recurrent Haemophilia A with anti factor VIII – Diagnostics Atypical haemolytic uraemic syndrome Burkitt’s lymphoma – Diagnostics Hepatoblastoma – Life with Disease Pleural mesothelioma malignant More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amcenestrant Magnesium Citrate Lavender Oil Minoxidil Pilocarpine Hydrochloride Altizide Enalapril Timrepigene Emparvovec Bcmacp03 AMG 732 LIGUFALIMAB Benfotiamine Betahistine Dihydrochloride Caffeine Citrate Vimseltinib GSK4418959A Azd0901 Triheptanoin Nimorazole 64Cu-Dota-Ae105 More therapies…

    Learn about Your Condition

    Renal disorder Takayasu's arteritis Familial hypertriglyceridaemia Chondropathy Prostate cancer metastatic Immune thrombocytopenia Gaucher's disease type I Adrenal insufficiency Medullary thyroid cancer Lung adenocarcinoma stage III Psychotic disorder Eclampsia Bronchiolitis Precocious puberty Dry mouth More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Overweight

  • A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Osteoarthritis
    • Overweight
    Bulgaria Denmark Greece Italy Poland Spain

  • A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Osteoarthritis
    • Overweight
    Bulgaria Denmark Greece Italy Poland Spain

  • A study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • LY3841136 SODIUM
    Belgium Germany Poland

  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    • Obesity
    • Overweight
    Investigated Drugs:
    • Medroxyprogesterone Acetate
    • Dydrogesterone
    • Glucose
    Germany

  • Study on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    • Obesity
    • Overweight
    Investigated Drugs:
    • Semaglutide
    • Sodium Chloride
    Denmark

  • Study on the Effectiveness and Safety of Orforglipron for Weight Management in Adolescents with Obesity or Overweight

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Italy Poland
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!